A key limitation of this study is that the numbers of patients with CRC and IDA are small in some categories of f-Hb and age, meaning that our analysis of CRC risk in these groups generated wide CIs and should be interpreted with caution. This evidence concerns the gene GSTM1 and colorectal carcinoma.